Live Attenuated Varicella Vaccine: Protection in Healthy Adults Compared with Leukemic Children

Protection against varicella infection was assessed in leukemic children and healthy young adults who were immunized with live attenuated varicella vaccine. Attack rates of breakthrough infection following household exposure to varicella in 102 children and 26 adults were similar whether one or two...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 161; no. 4; pp. 661 - 666
Main Authors Gershon, Anne A., Steinberg, Sharon R
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.04.1990
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Protection against varicella infection was assessed in leukemic children and healthy young adults who were immunized with live attenuated varicella vaccine. Attack rates of breakthrough infection following household exposure to varicella in 102 children and 26 adults were similar whether one or two doses of vaccine had been given. The mild breakthrough illness wasalso similar after one or more doses. Specific antibody titers were similar 1 year after immunization whether individuals had received one or two doses. Humoral and cell-mediated immunity to varicella-zoster virus (VZV) was lower in these vaccinees than in persons who had experienced natural varicella infection. Protection after natural infection in adult family members exposed to varicella was superior to that in vaccinees; none developed varicella infection. These observations suggest that immunization induces less protection than does natural disease in leukemic children and young adults. This may be partly due to the nature of the vaccine virus, but because responses ofadults were similar to those of leukemic children, it suggests also that both of these groups have impaired immune responses to VZV. Boosting of humoral immunity after exposure to VZV was common and was observed in healthy adults with past natural infection and in vaccinated adults and leukemic children.
Bibliography:istex:7A7F6EF42036098C1A0DC6FDA5A69AD4F814E7AE
ark:/67375/HXZ-KGDSVS53-B
Reprints and correspondence: Dr. Anne Gershon, Columbia Presbyterian Medical Center, Department of Pediatrics, Black Building, 650 W. 168th St., New York, NY 10032.
See acknowledgment for names of members.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/161.4.661